Biology Reference
In-Depth Information
Trimble LA, Shankar P, Patterson M, Daily JP, Lieberman J. 2000. Human immunode®ciency
virus-speci®c circulating CD8 T lymphocytes have down-modulated CD3zeta and CD28, key
signaling molecules for T- cell activation. J Virol 74: 7320±7330.
Valdez H, Smith KY, Landay A, Connick E, Kuritzkes DR, Kessler H, Fox L, Spritzler J, Roe J,
Lederman MB, et al. 2000. Response to immunization with recall and neoantigens after pro-
longed administration of an HIV-1 protease inhibitor-containing regimen. ACTG 375 team.
AIDS Clinical Trials Group. AIDS 14: 11±21.
Weekes MP, Carmichael AJ, Wills MR, Mynard K, Sissons JG. 1999. Human CD28
ÿ
CD8
T cells
contain greatly expanded functional virus-speci®c memory CTL clones. J Immunol 162: 7569±
7577.
Weidt G, Utermohlen O, Heukeshoven J, Lehmann-Grube F, Deppert W. 1998. Relationship
among immunodominance of single CD8
T cell epitopes, virus load, and kinetics of primary
antiviral CTL response. J Immunol 160: 2923±2931.
Whitmire JK, Murali-Krishna K, Altman J, Ahmed R. 2000. Antiviral CD4 and CD8 T-cell
memory: di¨erences in the size of the response and activation requirements. Philos Trans R Soc
Lond B Biol Sci 355: 373±379.
Wilson JD, Ogg GS, Allen RL, Goulder PJ, Kelleher A, Sewell AK, O'Callaghan CA, Rowland-
Jones SL, Callan MF, McMichael AJ. 1998. Oligoclonal expansions of CD8() T cells in
chronic HIV infection are antigen speci®c. J Exp Med 188: 785±790.
Wilson JD, Ogg GS, Allen RL, Davis C, Shaunak S, Downie J, Dyer W, Workman C, Sullivan S,
McMichael AJ, Rowland-Jones SL. 2000. Direct visualization of HIV-1-speci®c cytotoxic T
lymphocytes during primary infection. AIDS 14: 225±233.
Zajac AJ, Blattman JN, Murali-Krishna K, Sourdive DJ, Suresh M, Altman JD, Ahmed R. 1998.
Viral immune evasion due to persistence of activated T cells without e¨ector function. Exp Med
188: 2205±2213.
Zhang ZQ, Schuler T, Cavert W, Notermans DW, Gebhard K, Henry K, Havlir DV, Gunthard
HF, Wong JK, Little S, et al. 1999. Reversibility of the pathological changes in the follicular
dendritic cell network with treatment of HIV-1 infection. Proc Natl Acad Sci USA 96: 5169±
5172.
